Home > Financial Ratios > SAKAR HEALTHCARE

SAKAR HEALTHCARE
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for SAKAR HEALTHCARE
Please provide your vote to see the results

SAKAR HEALTHCARE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 9.5620.4132.4710.29-

What is the latest Core EBITDA Growth ratio of SAKAR HEALTHCARE ?

The latest Core EBITDA Growth ratio of SAKAR HEALTHCARE is 9.56 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar20249.56
Mar202320.41
Mar202232.47
Mar202110.29
Mar2020-

How is Core EBITDA Growth of SAKAR HEALTHCARE Trending?

Years Core EBITDA Growth % Change
Mar2024 9.56
-53.16
Mar2023 20.41
-37.14
Mar2022 32.47
215.55
Mar2021 10.29
0
Mar2020 0 -

Other Financial Ratios of SAKAR HEALTHCARE


Compare Core EBITDA Growth ratio of peers of SAKAR HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAKAR HEALTHCARE ₹790.3 Cr -2.9% -3.4% 13.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,804.0 Cr -0.2% 3.6% -7.8% Stock Analytics
DIVIS LABORATORIES ₹170,764.0 Cr -2.4% 9.1% 13.4% Stock Analytics
CIPLA ₹126,807.0 Cr -5.7% 4% 6.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,099.0 Cr -0.3% 1.3% 8.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,707.0 Cr 0.1% 1.2% -2.8% Stock Analytics


SAKAR HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAKAR HEALTHCARE

-2.9%

-3.4%

13.5%

SENSEX

0.3%

3.6%

5.5%


You may also like the below Video Courses